Use of cholesterol-lowering agent
CA 2358641 A1 · Owner: Raza, Ali · Inventors: Raza, Ali
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the use of particular oral dosages or dosage ranges of the compound (E) -7 -4 -(4 -fluorophenyl) -6 -isopropyl -2 methyl(methylsulfonyl)aminopyrimidin -5 -yl -(3R,5S) -3,5 -dihydr oxyhept - 6 -enoic acid or a pharmaceutically acceptable salt thereof to alter , beneficially lipid levels or lipid ratios in a human patient in need thereof as well as pharmaceutical compositions of said compound or salts adapted for oral administration which comprise such dosages and methods of preparation , thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 1, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 1, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 1, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.